HIM
ATRC icon

Hillsdale Investment Management’s AtriCure ATRC Stock Holding History

Hillsdale Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120
Closed -$4.28K – 592
2023
Q4 		$4.28K Hold
120
– – ﹤0.01% 550
2023
Q3 		$5.26K Buy
120
+50
+71% +$2.44K ﹤0.01% 501
2023
Q2 		$3.46K Buy
+70
New +$3.23K ﹤0.01% 497

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hillsdale Investment Management's ATRC Position: Q1 2024 in Review

Hillsdale Investment Management sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 120 shares — an estimated $4.28K sold.

Hillsdale Investment Management first reported a position in ATRC in Q2 2023 and held it in 3 quarters. The position peaked at $5.26K in Q3 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • Hillsdale Investment Management reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 120 AtriCure shares in Q1 2024, an estimated $4.28K.
  • Hillsdale Investment Management first reported a position in AtriCure in Q2 2023 and held it in 3 quarters.
  • Hillsdale Investment Management's AtriCure position peaked at $5.26K in Q3 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Hillsdale Investment Management's 13F filing for Q1 2024, filed 10 May 2024.